J&J to buy Proteologix and its dual-targeting antibody drugs for $850M

An article from site logo

The deal is the third large purchase for J&J this year and hands the company a pair of medicines in development for eczema and asthma.

A sign is posted at…
Click here to view original post

Click Here to Publish/Feature Your Company or Product News with Biotech Networks